
Nicholas J. Weiss
Examiner (ID: 18899, Phone: (571)270-1775 , Office: P/3754 )
| Most Active Art Unit | 3754 |
| Art Unit(s) | 3754, 3711, 3781 |
| Total Applications | 524 |
| Issued Applications | 306 |
| Pending Applications | 35 |
| Abandoned Applications | 187 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20444003
[patent_doc_number] => 20260000717
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-01-01
[patent_title] => MODULATION OF THE GUT MICROBIOME TO TREAT MENTAL DISORDERS OR DISEASES OF THE CENTRAL NERVOUS SYSTEM
[patent_app_type] => utility
[patent_app_number] => 19/267001
[patent_app_country] => US
[patent_app_date] => 2025-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28850
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19267001
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/267001 | MODULATION OF THE GUT MICROBIOME TO TREAT MENTAL DISORDERS OR DISEASES OF THE CENTRAL NERVOUS SYSTEM | Jul 10, 2025 | Pending |
Array
(
[id] => 20729077
[patent_doc_number] => 12636321
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-05-26
[patent_title] => Composition
[patent_app_type] => utility
[patent_app_number] => 19/250795
[patent_app_country] => US
[patent_app_date] => 2025-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 0
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19250795
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/250795 | Composition | Jun 25, 2025 | Issued |
Array
(
[id] => 20246753
[patent_doc_number] => 20250295622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-25
[patent_title] => Animal Feeds and Feed Premixes Containing Betaine Hydrochloride and a Phytase
[patent_app_type] => utility
[patent_app_number] => 19/230710
[patent_app_country] => US
[patent_app_date] => 2025-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5655
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19230710
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/230710 | Animal feeds and feed premixes containing betaine and a phytase | Jun 5, 2025 | Issued |
Array
(
[id] => 20406377
[patent_doc_number] => 20250375486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-12-11
[patent_title] => REGULATE GUT MICROBIOTA TO TREAT NEURODEGENERATIVE DISORDERS
[patent_app_type] => utility
[patent_app_number] => 19/212317
[patent_app_country] => US
[patent_app_date] => 2025-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15787
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19212317
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/212317 | REGULATE GUT MICROBIOTA TO TREAT NEURODEGENERATIVE DISORDERS | May 18, 2025 | Pending |
Array
(
[id] => 20163963
[patent_doc_number] => 20250256009
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-14
[patent_title] => DECELLULARIZED BIOMATERIAL FROM NON-MAMMALIAN TISSUE
[patent_app_type] => utility
[patent_app_number] => 19/195843
[patent_app_country] => US
[patent_app_date] => 2025-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4882
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19195843
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/195843 | DECELLULARIZED BIOMATERIAL FROM NON-MAMMALIAN TISSUE | Apr 30, 2025 | Pending |
Array
(
[id] => 20293891
[patent_doc_number] => 20250319134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-10-16
[patent_title] => TREATMENT OF IMMUNE DISORDERS
[patent_app_type] => utility
[patent_app_number] => 19/030861
[patent_app_country] => US
[patent_app_date] => 2025-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13966
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19030861
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/030861 | Treatment of immune disorders | Jan 16, 2025 | Issued |
Array
(
[id] => 20356263
[patent_doc_number] => 12472242
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-18
[patent_title] => Proteolytic enzyme composition
[patent_app_type] => utility
[patent_app_number] => 19/022162
[patent_app_country] => US
[patent_app_date] => 2025-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 297
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19022162
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/022162 | Proteolytic enzyme composition | Jan 14, 2025 | Issued |
Array
(
[id] => 19860773
[patent_doc_number] => 20250099559
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-27
[patent_title] => STABILIZED LIQUID AND LYOPHILIZED ADAMTS13 FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 18/952409
[patent_app_country] => US
[patent_app_date] => 2024-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39641
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18952409
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/952409 | STABILIZED LIQUID AND LYOPHILIZED ADAMTS13 FORMULATIONS | Nov 18, 2024 | Pending |
Array
(
[id] => 20149245
[patent_doc_number] => 20250249083
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-07
[patent_title] => PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF THE SYMPTOMS OF ADDICTION AND METHOD OF DIAGNOSING SAME
[patent_app_type] => utility
[patent_app_number] => 18/887646
[patent_app_country] => US
[patent_app_date] => 2024-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18887646
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/887646 | PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF THE SYMPTOMS OF ADDICTION AND METHOD OF DIAGNOSING SAME | Sep 16, 2024 | Abandoned |
Array
(
[id] => 20246813
[patent_doc_number] => 20250295682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-25
[patent_title] => USE OF NUCLEOTIDE OF LACTOBACILLUS FERMENTUM GM-090 FOR PREPARING PHARMACEUTICAL COMPOSITION FOR REGULATING IMMUNITY
[patent_app_type] => utility
[patent_app_number] => 18/791967
[patent_app_country] => US
[patent_app_date] => 2024-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18791967
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/791967 | USE OF NUCLEOTIDE OF LACTOBACILLUS FERMENTUM GM-090 FOR PREPARING PHARMACEUTICAL COMPOSITION FOR REGULATING IMMUNITY | Jul 31, 2024 | Pending |
Array
(
[id] => 19746048
[patent_doc_number] => 20250034613
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-30
[patent_title] => ENGINEERED PROBIOTICS FOR DETECTION OF GASTROINTESTINAL DISEASE IN HUMANS
[patent_app_type] => utility
[patent_app_number] => 18/775012
[patent_app_country] => US
[patent_app_date] => 2024-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10335
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18775012
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/775012 | ENGINEERED PROBIOTICS FOR DETECTION OF GASTROINTESTINAL DISEASE IN HUMANS | Jul 16, 2024 | Pending |
Array
(
[id] => 19643238
[patent_doc_number] => 20240417758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-19
[patent_title] => PROCESSES FOR FIXATION OF CARBON DIOXIDE
[patent_app_type] => utility
[patent_app_number] => 18/740693
[patent_app_country] => US
[patent_app_date] => 2024-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11217
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -84
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18740693
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/740693 | PROCESSES FOR FIXATION OF CARBON DIOXIDE | Jun 11, 2024 | Pending |
Array
(
[id] => 20644218
[patent_doc_number] => 12599140
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-04-14
[patent_title] => Agricultural compositions and methods for the delivery of plant health-promoting microbes
[patent_app_type] => utility
[patent_app_number] => 18/653104
[patent_app_country] => US
[patent_app_date] => 2024-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 12
[patent_no_of_words] => 0
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 220
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18653104
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/653104 | Agricultural compositions and methods for the delivery of plant health-promoting microbes | May 1, 2024 | Issued |
Array
(
[id] => 20436880
[patent_doc_number] => 12507697
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-30
[patent_title] => Population genetics approach to biological control of mycotoxin production
[patent_app_type] => utility
[patent_app_number] => 18/631626
[patent_app_country] => US
[patent_app_date] => 2024-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 22
[patent_no_of_words] => 22823
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 231
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18631626
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/631626 | Population genetics approach to biological control of mycotoxin production | Apr 9, 2024 | Issued |
Array
(
[id] => 20076214
[patent_doc_number] => 12350248
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-08
[patent_title] => Animal feeds and feed premixes containing betaine hydrochloride and a phytase
[patent_app_type] => utility
[patent_app_number] => 18/625676
[patent_app_country] => US
[patent_app_date] => 2024-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5720
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18625676
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/625676 | Animal feeds and feed premixes containing betaine hydrochloride and a phytase | Apr 2, 2024 | Issued |
Array
(
[id] => 19526737
[patent_doc_number] => 20240350639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-24
[patent_title] => CLINICAL FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 18/606927
[patent_app_country] => US
[patent_app_date] => 2024-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30040
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18606927
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/606927 | Clinical formulations | Mar 14, 2024 | Issued |
Array
(
[id] => 19447336
[patent_doc_number] => 20240307466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-19
[patent_title] => Methods and Compositions Relating to Microbial Treatment and Diagnosis of Disorders
[patent_app_type] => utility
[patent_app_number] => 18/589142
[patent_app_country] => US
[patent_app_date] => 2024-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30527
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18589142
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/589142 | Methods and compositions relating to microbial treatment and diagnosis of disorders | Feb 26, 2024 | Issued |
Array
(
[id] => 19345568
[patent_doc_number] => 20240254531
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => Enhancing Coupled Catalytic Activity of Multi-Enzyme Cascades With Liquid-Liquid Phase Separation Using Peptide-Based Condensates
[patent_app_type] => utility
[patent_app_number] => 18/425004
[patent_app_country] => US
[patent_app_date] => 2024-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1787
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18425004
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/425004 | Enhancing Coupled Catalytic Activity of Multi-Enzyme Cascades With Liquid-Liquid Phase Separation Using Peptide-Based Condensates | Jan 28, 2024 | Pending |
Array
(
[id] => 19862582
[patent_doc_number] => 20250101368
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-27
[patent_title] => CULTURE MATERIAL AND CULTIVATION METHOD OF GANODERMA AMBOINENSE
[patent_app_type] => utility
[patent_app_number] => 18/413084
[patent_app_country] => US
[patent_app_date] => 2024-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2952
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18413084
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/413084 | CULTURE MATERIAL AND CULTIVATION METHOD OF GANODERMA AMBOINENSE | Jan 15, 2024 | Pending |
Array
(
[id] => 19188072
[patent_doc_number] => 20240166985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => STIFF, RIGID MYCELIUM-BASED BIOCOMPOSITE MATERIAL FOR USE IN STRUCTURAL AND NON-STRUCTURAL APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 18/407050
[patent_app_country] => US
[patent_app_date] => 2024-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11169
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18407050
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/407050 | STIFF, RIGID MYCELIUM-BASED BIOCOMPOSITE MATERIAL FOR USE IN STRUCTURAL AND NON-STRUCTURAL APPLICATIONS | Jan 7, 2024 | Pending |